Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms
Christopher Fernandez-Prada Isabel M. Vincent Marie-Christine Brotherton Mathew Roberts Gaétan Roy Luis Rivas Philippe Leprohon Terry K. Smith Marc Ouellette Louis Maes
Luis Rivas
Rivas Luis
ORCID: 0000-0002-2958-3233
Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis 10.1128/AAC.00790-10
The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase 10.1128/AAC.00520-11
Platelet-activating factor receptor contributes to antileishmanial function of miltefosine 10.4049/jimmunol.1401890
The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation 10.1016/j.bbamcr.2005.11.003
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii 10.1007/s10096-011-1233-y
Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists 10.1016/j.ejmech.2010.08.054
Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania 10.1096/fj.07-096081
Expression and regulation of mitochondrial uncoupling protein 1 from brown adipose tissue in Leishmania major promastigotes 10.1016/S0166-6851(98)00029-2
Developmental Life Cycle of Leishmania—Cultivation and Characterization of Cultured Extracellular Amastigotes 10.1111/j.1550-7408.1993.tb04906.x
Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents 10.1021/mp8001039
Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis 10.1371/journal.pntd.0001927
Amphibian antimicrobial peptides and Protozoa: Lessons from parasites 10.1016/j.bbamem.2008.11.002
New Benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II 10.1021/jm901677h
The cost of resistance to colistin in Acinetobacter baumannii: A proteomic perspective 10.1002/pmic.200800434
Characterization of the leishmanicidal activity of antimicrobial peptides. 10.1007/978-1-60761-594-1_25
Phosphorylation of the N-terminal and C-terminal CD3-ε-ITAM tyrosines is differentially regulated in T cells 10.1006/bbrc.2002.6492
Impaired virulence and in vivo fitness of colistin-resistant acinetobacter baumannii 10.1093/infdis/jiq086
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targets 10.1021/mp100035f
Safety and Efficacy of Antimicrobial Peptides against Naturally Acquired Leishmaniasis 10.1128/AAC.48.2.641-643.2004
Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages 10.1074/jbc.M311516200
Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (Miltefosine) as probes of antiparasite mechanisms 10.1021/jm070595+
A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug 10.1007/s00726-013-1661-3
Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine 10.1016/j.bmcl.2008.10.089
Activities of polymyxin B and cecropin A-melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii 10.1128/AAC.46.3.875-878.2002
Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania 10.1007/s00216-014-7772-1
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms 10.1371/journal.pntd.0005171
Erratum to "Interaction studies of diacyl glycerol arginine-based surfactants with DPPC and DMPC monolayers, relation with antimicrobial activity" [Colloids Surf. A: Physicochem. Eng. Aspects 319 (2008) 196-203] (DOI:10.1016/j.colsurfa.2007.07.015) 10.1016/j.colsurfa.2009.08.032
A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides 10.1096/fj.04-1515fje
Genomic appraisal of the multifactorial basis for in vitro acquisition of Miltefosine resistance in Leishmania donovani 10.1128/AAC.00478-16
Release of lipid vesicle contents by an antibacterial cecropin A- melittin hybrid peptide 10.1021/bi953058c
Role of positional hydrophobicity in the leishmanicidal activity of magainin 2 10.1128/AAC.48.8.2980-2986.2004
Mechanisms of action of substituted β-amino alkanols on leishmania donovani 10.1128/AAC.04003-14
Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: Molecular basis for the differential mechanisms of action 10.1128/AAC.50.4.1251-1256.2006
Leishmania infantum Modulates Host Macrophage Mitochondrial Metabolism by Hijacking the SIRT1-AMPK Axis 10.1371/journal.ppat.1004684
Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes 10.1128/AAC.01415-06
Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: A proof of mechanism for trypanosomatid chemotherapy 10.1016/j.jconrel.2012.05.023
Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-α production by macrophages 10.1177/1753425908100500
Riboflavin derivatives for enhanced photodynamic activity against Leishmania parasites 10.1016/j.tet.2014.11.072
CE-ESI-MS metabolic fingerprinting of Leishmania resistance to antimony treatment 10.1002/elps.201200007
Solid-phase synthesis of the cyclic lipononadepsipeptide [N-Mst(Ser1), D-Ser4, L-Thr6, L-Asp8, L-Thr9]syringotoxin 10.1002/chem.200390126
Fungus-Elicited Metabolites from Plants as an Enriched Source for New Leishmanicidal Agents: Antifungal Phenyl-Phenalenone Phytoalexins from the Banana Plant (Musa acuminata) Target Mitochondria of Leishmania donovani Promastigotes 10.1128/AAC.48.5.1534-1540.2004
In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci 10.1128/AAC.01428-06
Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes 10.1016/j.imbio.2005.05.013
Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin 10.1007/s00726-012-1304-0
The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers 10.1042/BJ20030815
Animal antimicrobial peptides: An overview 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes 10.1074/jbc.M205270200
Leishmania donovani: Thionins, plant antimicrobial peptides with leishmanicidal activity 10.1016/j.exppara.2009.03.019
Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H 10.1021/bi052150y
Acidid pH stress induces protein tyrosine phosphorylation in Leishmania pifanoi 10.1016/S0166-6851(96)02789-2
Fluorescent labeling of Acanthamoeba assessed in situ from corneal sectioned microscopy 10.1364/BOE.3.002489
Permeabilization of the Mitochondrial Inner Membrane by Short Cecropin‐A–Melittin Hybrid Peptides 10.1111/j.1432-1033.1994.tb20019.x
Structural framework for the modulation of the activity of the hybrid antibiotic peptide cecropin A-melittin [CA(1-7)M(2-9)] by N ε-lysine trimethylation 10.1002/cbic.201100269
Lysine N ε-trimethylation, a tool for improving the selectivity of antimicrobial peptides 10.1021/jm100261r
Eukaryotic antibiotic peptides: A new alternative in clinics?,Péptidos antibióticos eucarióticos: ¿Una nueva alternativa en clínica? 10.1157/13050527
Synthesis of 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity 10.1016/j.bmcl.2006.07.004
A multiplatform metabolomic approach to the basis of antimonial action and resistance in Leishmania infantum 10.1371/journal.pone.0130675
Biochemical characterization of the protective membrane glycoprotein GP46/M-2 of Leishmania amazonensis 10.1016/0166-6851(91)90183-7
Antimicrobial peptide action on parasites 10.2174/138945012802002393
Cytokines and infectious diseases 10.1016/S0167-5699(96)30069-8
Intrinsic structural differences in the N-terminal segment of pulmonary surfactant protein SP-C from different species 10.1016/S1095-6433(01)00310-5
The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases 10.1016/0166-6851(94)00157-X
Sequence inversion and phenylalanine surrogates at the β-Turn enhance the antibiotic activity of gramicidin S 10.1021/jm100143f
N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide 10.1128/AAC.45.9.2441-2449.2001
Virulence and disease in leishmaniasis: What is relevant for the patient? 10.1016/j.pt.2004.05.005
Temporins, small antimicrobial peptides with leishmanicidal activity 10.1074/jbc.M410795200
In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism 10.1128/AAC.45.4.1121-1125.2001
Membrane-active peptides as anti-infectious agents 10.2478/v10136-009-0019-3
Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the β-turn 10.1021/jm800886n
Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP 10.1042/BJ20030544
Co-infection with HIV 10.1007/978-3-7091-1125-3_8
AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN 10.1128/AAC.01289-06
Eukaryotic antibiotic peptides: Not only a membrane business 10.1016/S1359-6446(99)01358-6
Interaction studies of diacyl glycerol arginine-based surfactants with DPPC and DMPC monolayers, relation with antimicrobial activity 10.1016/j.colsurfa.2007.07.015
Conjugation of quinones with natural polyamines: Toward an expanded antitrypanosomatid profile 10.1021/jm301112z
Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism 10.1016/j.ijpddr.2013.11.002
Influence of lysine Nε-trimethylation and lipid composition on the membrane activity of the cecropin A-melittin hybrid peptide CA(1-7)M(2-9) 10.1021/jp106915c
Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii 10.1093/jac/dkl145
A Synthetic Strategy for Conjugation of Paromomycin to Cell-Penetrating Tat(48-60) for Delivery and Visualization into Leishmania Parasites 10.1155/2017/4213037
Drug Discovery for Leishmaniasis 10.1039/9781788010177
Drug repurposing for Leishmania. Molecular basis of the leishmanicidal activity of the antidepressant sertraline. 10.1128/aac.01928-18
Widening the antimicrobial spectrum of esters of bicyclic amines: In vitro effect on gram-positive Streptococcus pneumoniae and gram-negative non-typeable Haemophilus influenzae biofilms 10.1016/j.bbagen.2018.10.001
Design of Bactericidal Peptides Against Escherichia coli O157:H7, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus 10.2174/1573406414666180508120024
Recombinant vs native Anisakis haemoglobin (Ani s 13): Its appraisal as a new gold standard for the diagnosis of allergy 10.1016/j.exppara.2017.08.010
Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release 10.1038/cddis.2017.390
Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents 10.1128/aac.02288-16
Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice 10.1371/journal.pntd.0005281
Chemistry and Applications of Synthetic Antimicrobial Peptides 10.1201/9780203910801.pt1
Cecropin–melittin hybrid peptides as versatile templates in the development of membrane-active antibiotic agents1 10.1201/9780203986646.ch11
Characterization of Developmentally Regulated Molecules of Leishmania 10.1007/978-3-642-72840-2_14
Chapter 13 The Physical Matrix of the Plasma Membrane as a Target: The Charm of Drugs with Low Specificity 10.1039/9781788010177-00248
The antenna system of Rhodospirillum rubrum. Detection of macromolecular constituents not stainable by Coomassie brilliant blue in solubilized preparations of the B880 complex 10.1007/bf00037005
Topography of the subunits of Micrococcus lysodeikticus F1-ATPase 10.1007/bf00228771
Partial characterization of membrane-associated proteinases from Micrococcus lysodeikticus 10.1007/bf00229536
Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3 10.1080/14756366.2019.1693704
Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold 10.1016/j.ejmech.2019.03.007
Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani 10.1016/j.ejmech.2019.111568
Morphogenesis of the human laryngeal ventricles 10.1002/hed.22970
Cyanobacterial peptides as a tour de force in the chemical space of antiparasitic agents 10.1016/j.abb.2019.01.030
Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine 10.1007/s00436-019-06419-2
Proteolytic activities in preparations of Rhodospirillum rubrum reaction centers 10.1016/0005-2728(84)90021-5
Isolation of Two Pyruvate Kinase Activities in the Parasitic Protozoan Leishmania mexicana amazonensis 10.1006/abbi.1993.1063
Comparative study on polypeptide patterns of larvae of Trichinella isolates by two-dimensional electrophoresis 10.1017/S0022149X00010051
Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium 10.1016/j.ophtha.2011.10.031
Effect of substituents in the A and B rings of chalcones on antiparasite activity 10.1002/ardp.202000157
Animal antimicrobial peptides: An overview 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
Hybrid Cyclobutane/Proline-Containing Peptidomimetics: The Conformational Constraint Influences Their Cell-Penetration Ability 10.3390/ijms22105092
Isabel Vincent
Vincent Isabel
ORCID: 0000-0003-2663-4389
TrypanoCyc: A community-led biochemical pathways database for Trypanosoma brucei 10.1093/nar/gku944
Metabolomic-based strategies for anti-parasite drug discovery 10.1177/1087057114551519
Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism 10.1016/j.ijpddr.2013.11.002
LM14 defined medium enables continuous growth of Trypanosoma cruzi 10.1186/s12866-014-0238-y
The threonine degradation pathway of the Trypanosoma brucei procyclic form: The main carbon source for lipid biosynthesis is under metabolic control 10.1111/mmi.12351
Pharmacological Metabolomics in Trypanosomes 10.1002/9783527670383.ch3
Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against trypanosoma brucei 10.1371/journal.pntd.0001618
Drug resistance in human African trypanosomiasis 10.2217/fmb.11.88
A molecular mechanism for eflornithine resistance in African trypanosomes 10.1371/journal.ppat.1001204
Sixth Exploratory Measurement Science Group symposium 10.1586/epr.09.88
Polymeric hydrophilic interaction liquid chromatography coupled with Orbitrap mass spectrometry and chemometric analysis for untargeted metabolite profiling of natural rice variants 10.1016/j.jcs.2017.01.001
Untargeted metabolomics to ascertain antibiotic modes of action 10.1128/AAC.02109-15
Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis 10.1371/journal.pntd.0005140
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms 10.1371/journal.pntd.0005171
The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing 10.1371/journal.ppat.1007315
Mitochondrial proteomics of antimony and miltefosine resistant Leishmania infantum 10.3390/proteomes3040328
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei 10.1371/journal.pntd.0006450
Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles 10.1371/journal.ppat.1006850
Chapter 6: Omics and Their Impact on the Development of Chemotherapy Against Leishmania 10.1039/9781788010177-00101
Metabolomic profiling of macrophages determines the discrete metabolomic signature and metabolomic interactome triggered by polarising immune stimuli 10.1371/journal.pone.0194126
Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana 10.1371/journal.pntd.0005649
Decomposing metabolite set activity levels with PALS 10.1101/2020.06.07.138974
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs 10.1371/journal.ppat.1008932
Ranking Metabolite Sets by Their Activity Levels 10.3390/metabo11020103
Marc Ouellette
Ouellette Marc
ORCID: 0000-0002-6743-9646
Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics 10.2217/fmb-2016-0113
Chromosomal Translocations in the Parasite Leishmania by a MRE11/RAD50-Independent Microhomology-Mediated End Joining Mechanism 10.1371/journal.pgen.1006117
Coordinating funding in public health emergencies 10.1016/S0140-6736(16)30604-3
Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania 10.1073/pnas.1520693113
Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance 10.1007/s00436-016-5195-y
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms 10.1371/journal.pntd.0005171
Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination 10.1099/jmm.0.000202
Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance 10.12688/f1000research.9218.1
The initial state of the human gut microbiome determines its reshaping by antibiotics 10.1038/ismej.2015.148
Use of phylogenetical analysis to predict susceptibility of pathogenic Candida spp. to antifungal drugs 10.1016/j.mimet.2016.09.020
A genomic approach to understand interactions between Streptococcus pneumoniae and its bacteriophages 10.1186/s12864-015-2134-8
Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae 10.1128/AAC.00316-15
Drug resistance analysis by next generation sequencing in Leishmania 10.1016/j.ijpddr.2014.09.005
Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major 10.1016/j.molbiopara.2015.07.003
Inactivation of the cytosolic and mitochondrial serine hydroxymethyl transferase genes in Leishmania major 10.1016/j.molbiopara.2016.02.003
Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA 10.1093/jac/dkv211
Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis 10.1371/journal.pntd.0003476
Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum 10.3390/proteomes3040328
Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing 10.1093/jac/dkv060
Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada 10.1080/21645515.2015.1083663
On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon 10.3389/fmicb.2015.01020
Roles of Rad51 paralogs for promoting homologous recombination in Leishmania infantum 10.1093/nar/gkv118
Separation of basic proteins from Leishmania using a combination of Free flow electrophoresis (FFE) and 2D electrophoresis (2-DE) under basic conditions 10.1007/978-1-4939-1438-8_15
DNA repair pathways in trypanosomatids: from DNA repair to drug resistance 10.1128/MMBR.00045-13
Formation of linear amplicons with inverted duplications in Leishmania requires the MRE11 nuclease 10.1371/journal.pgen.1004805
Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania 10.1371/journal.pbio.1001868
Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates 10.1128/AAC.01311-13
Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum 10.1016/j.ijpddr.2014.05.002
The impact of distinct culture media in Leishmania infantum biology and infectivity 10.1017/S0031182013001388
Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism 10.1016/j.ijpddr.2013.11.002
Exoproteome dynamics in Leishmania infantum 10.1016/j.jprot.2013.03.012
Gene amplification and point mutations in pyrimidine metabolic genes in 5-fluorouracil resistant Leishmania infantum 10.1371/journal.pntd.0002564
Gene expression modulation and the molecular mechanisms involved in Nelfinavir resistance in Leishmania donovani axenic amastigotes 10.1111/mmi.12298
Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae 10.1093/jac/dkt113
Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae 10.1128/AAC.00418-13
Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant 10.1371/journal.pone.0081899
Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania 10.1111/mmi.12178
Analysis of membrane-enriched and high molecular weight proteins in Leishmania infantum promastigotes and axenic amastigotes 10.1021/pr201248h
Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis 10.1016/j.molbiopara.2012.03.002
Generation of Leishmania hybrids by whole genomic DNA transformation 10.1371/journal.pntd.0001817
Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan 10.1371/journal.pntd.0001463
Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species 10.1093/nar/gkr834
Interactions between BRCA2 and RAD51 for promoting homologous recombination in Leishmania infantum 10.1093/nar/gks306
Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing 10.1371/journal.pntd.0001512
ABC transporters involved in drug resistance in human parasites 10.1042/bse0500121
Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis 10.1371/journal.pntd.0001167
Genome annotation and intraviral interactome for the Streptococcus pneumoniae virulent phage Dp-1 10.1128/JB.01117-10
Intrachromosomal tandem duplication and repeat expansion during attempts to inactivate the subtelomeric essential gene GSH1 in Leishmania 10.1093/nar/gkr494
Proteomic and transcriptomic analysis of linezolid resistance in Streptococcus pneumoniae 10.1021/pr200221s
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania 10.1038/cddis.2011.83
Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations 10.1186/1471-2164-12-512
Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease 10.1186/gb-2011-12-11-r115
Analysis of stage-specific expression of basic proteins in Leishmania infantum 10.1021/pr100048m
High affinity S-Adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) family 10.1074/jbc.M110.114520
Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes 10.1371/journal.pntd.0000642
Structure-function analysis of the highly conserved charged residues of the membrane protein FT1, the main folic acid transporter of the protozoan parasite Leishmania 10.1016/j.bcp.2009.07.019
Coordinated gene expression by post-transcriptional regulons in African trypanosomes 10.1186/jbiol203
Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen 10.1016/j.exppara.2009.05.013
Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum 10.1093/nar/gkn1069
Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance 10.1101/gr.089342.108
Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials 10.1128/AAC.01474-08
Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum 10.1086/595710
The gamma-glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants 10.1111/j.1365-2958.2009.06907.x
The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania 10.1016/j.freeradbiomed.2008.10.034
Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum 10.1016/j.molbiopara.2008.12.012
A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes 10.1016/j.molbiopara.2007.11.008
Divergence among genes encoding the elongation factor Tu of Yersinia Species 10.1128/JB.01067-08
Functional analysis and complex gene rearrangements of the folate/biopterin transporter (FBT) gene family in the protozoan parasite Leishmania 10.1016/j.molbiopara.2008.08.007
Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species 10.1186/1471-2164-9-255
Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors 10.1086/592280
Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy 10.1186/gb-2008-9-7-r115
Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate 10.1128/AAC.01183-07
A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death 10.1074/mcp.M600319-MCP200
A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection 10.1099/vir.0.81995-0
Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis 10.1111/j.1365-2958.2007.05845.x
Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains 10.1021/pr070521m
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs 10.1007/s00436-007-0638-0
HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis 10.1086/510398
Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani 10.1093/jac/dkl494
Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes 10.1128/AAC.00404-07
A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum 10.1002/pmic.200500853
Identification of developmentally-regulated proteins in Leishmania panamensis by proteome profiling of promastigotes and axenic amastigotes 10.1016/j.molbiopara.2006.01.008
In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? 10.1099/vir.0.81647-0
Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites 10.1128/EC.00152-06
Prefractionation by digitonin extraction increases representation of the cytosolic and intracellular proteome of Leishmania infantum 10.1021/pr060081j
Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase 10.1128/AAC.50.1.88-95.2006
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection 10.1086/503371
Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania 10.1016/j.molbiopara.2006.06.009
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites 10.1371/journal.pmed.0030162
A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter 10.1111/j.1365-2958.2005.04914.x
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis 10.1128/IAI.73.10.6372-6382.2005
Microfluidic device for rapid (<15 min) automated microarray hybridization 10.1373/clinchem.2005.052845
Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania 10.1111/j.1365-2958.2005.04782.x
Phylogeny of the Enterobacteriaceae based on genes encoding elongation factor Tu and F-ATPase beta-subunit 10.1099/ijs.0.63539-0
Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes 10.1128/AAC.49.5.1988-1993.2005
Differential protein expression analysis of Leishmania major reveals novel roles for methionine adenosyltransferase and S-adenosylmethionine in methotrexate resistance 10.1074/jbc.M405183200
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin 10.1074/jbc.M403959200
Growth phase regulation of the main folate transporter of Leishmania infantum and its role in methotrexate resistance 10.1074/jbc.M409264200
Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate 10.1074/jbc.M400652200
Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam 10.1074/jbc.M404383200
Leishmaniasis: drugs in the clinic, resistance and new developments 10.1016/j.drup.2004.07.002
Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species 10.1128/JCM.42.8.3686-3695.2004
Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance 10.1074/jbc.M308352200
Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms 10.1074/mcp.M200085-MCP200
[Studies on the parasite Leishmania in the post-genomic era] 10.1051/medsci/20031910900
A new type of high affinity folic acid transporter in the protozoan parasite Leishmania and deletion of its gene in methotrexate-resistant cells 10.1074/jbc.M204796200
A proteomic approach to identify developmentally regulated proteins in Leishmania infantum 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G
Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the beta chain 10.1002/1521-4141(200201)32:1<50::AID-IMMU50>3.0.CO;2-A
Adaptation of Leishmania cells to in vitro culture results in a more efficient reduction and transport of biopterin 10.1006/expr.2001.4595
Development of a PCR assay for identification of staphylococci at genus and species levels 10.1128/JCM.39.7.2541-2547.2001
DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening 10.1128/AAC.45.4.1168-1173.2001
Gene amplification in amphotericin B-resistant Leishmania tarentolae 10.1006/expr.2001.4663
The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase 10.1074/jbc.M102351200
Binding of Mycoplasma arthritidis-derived mitogen to human MHC class II molecules via its N terminus is modulated by invariant chain expression and its C terminus is required for T cell activation 10.1002/1521-4141(200006)30:6<1748::AID-IMMU1748>3.0.CO;2-J
Rapid detection of group B streptococci in pregnant women at delivery 10.1056/NEJM200007203430303
ATP-binding cassette transporters: from multidrug resistance to genetic disease, Gosau, Austria, 20-27 February 1999 10.1054/drup.1999.0072
Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae 10.1093/emboj/18.9.2342
Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae 10.1093/emboj/16.11.3057
Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages 10.1093/emboj/16.10.2590
Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania 10.1006/expr.1997.4222
Pterin and folate reduction by the Leishmania tarentolae H locus short-chain dehydrogenase/reductase PTR1 10.1006/abbi.1997.0126
Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene 10.1006/expr.1996.4115
Gene disruption of the P-glycoprotein related gene pgpa of Leishmania tarentolae 10.1006/bbrc.1996.1098
New mechanisms of drug resistance in parasitic protozoa 10.1146/annurev.mi.49.100195.002235
Targeted insertion of the neomycin phosphotransferase gene into the tubulin gene cluster of Trypanosoma brucei 10.1038/348174a0
Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum 10.1371/journal.pntd.0009377
Christopher Fernandez-Prada
Fernandez-Prada Christopher / Christopher F Prada
ORCID: 0000-0003-4834-4956
Drug resistance analysis by next generation sequencing in Leishmania 10.1016/j.ijpddr.2014.09.005
Trypanosomatids see the light: Recent advances in bioimaging research 10.1016/j.drudis.2014.09.012
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery 10.1016/j.ijpddr.2014.07.006
Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from leishmania donovani with a mechanism different from that of camptothecin 10.3390/md11103661
Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB. 10.1371/journal.pone.0073565
Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect 10.1016/j.bcp.2013.02.024
A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity 10.1016/j.bbagen.2012.09.005
2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani 10.1016/j.bmcl.2012.08.019
Indotecan (LMP400) and AM13-55: Two novel indenoisoquinolines show potential for treating visceral leishmaniasis 10.1128/AAC.00499-12
First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the Leishmania topoisomerase IB enzyme 10.1351/PAC-CON-11-10-21
Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis 10.1016/j.molbiopara.2011.10.007
Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis 10.1371/journal.pntd.0001927
First total synthesis and antileishmanial activity of (Z)-16-methyl-11-heptadecenoic acid, a new marine fatty acid from the sponge Dragmaxia undata. 10.1016/j.chemphyslip.2010.11.006
DNA topoisomerases in apicomplexan parasites: Promising targets for drug discovery 10.1098/rspb.2009.2176
Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid 10.1007/s11745-009-3345-z
First total synthesis and antiprotozoal activity of (Z)-17-methyl-13-octadecenoic acid, a new marine fatty acid from the sponge Polymastia penicillus 10.1016/j.chemphyslip.2009.06.140
Novel findings on trypanosomatid chemotherapy using DNA topoisomerase inhibitors 10.2174/138955709788452775
Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania 10.1073/pnas.1520693113
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms 10.1371/journal.pntd.0005171
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms 10.1016/j.ijpddr.2018.03.004
High-throughput identification and quantification of Haemonchus contortus in fecal samples https://doi.org/10.1016/j.vetpar.2018.11.017
A review of the current evidence of fruit phenolic compounds as potential antimicrobials against pathogenic bacteria https://doi.org/10.1016/j.micpath.2019.03.025
Chapter 5 - Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases https://doi.org/10.1016/B978-0-12-816125-8.00005-5
Cos-Seq: A High-Throughput Gain-of-Function Screen for Drug Resistance Studies in Leishmania 10.1007/978-1-4939-9210-2_7
Leishmania and its exosomal pathway: a novel direction for vaccine development 10.2217/fmb-2019-0087
Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems 10.2174/1381612825666190621154552
Leishmania Viannia guyanensis 10.1016/j.pt.2019.06.008
High-throughput identification and quantification of Haemonchus contortus in fecal samples 10.1016/j.vetpar.2018.11.017
A review of the current evidence of fruit phenolic compounds as potential antimicrobials against pathogenic bacteria 10.1016/j.micpath.2019.03.025
Chapter 6: Omics and Their Impact on the Development of Chemotherapy Against Leishmania 10.1039/9781788010177-00101
Effects of recycled manure solids bedding on the spread of gastrointestinal parasites in the environment of dairies and milk 10.3168/jds.2019-16866
MRPA-independent mechanisms of antimony resistance in Leishmania infantum 10.1016/j.ijpddr.2020.03.003
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery 10.3390/genes11070722
Unravelling the proteomic signature of extracellular vesicles released by drug-resistant Leishmania infantum parasites 10.1371/journal.pntd.0008439
Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development 10.1016/j.molimm.2021.04.003
Extracellular Vesicles in Trypanosomatids: Host Cell Communication. 10.3389/fcimb.2020.602502
Three Different Mutations in the DNA Topoisomerase 1B in Leishmania Infantum Contribute to Resistance to Antitumor Drug Topotecan 10.21203/rs.3.rs-527648/v1
Influence of N-Methylation and Conformation on Almiramide Anti-Leishmanial Activity 10.3390/molecules26123606
Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan 10.1186/s13071-021-04947-4